Cancer Immunotherapy Month is a series of educational and social events designed to raise awareness of this promising new cancer treatment. Check out some of the exciting activities we have planned for you!
Meet Oswald. Following diagnosis with stage 4 non-small cell lung cancer, he began first-line treatment with a PD-L1 checkpoint immunotherapy. Today, he is cancer-free..
Learn about headline-grabbing research, practice-changing medicine, and new innovations in cancer immunotherapy from the world's largest oncology conference.
National Cancer Survivors Day® is a celebration for those who have survived, an inspiration for those recently diagnosed, a gathering of support for families, and an outreach to the community.
Join the global awareness day and discover A Future Immune to Cancer. Honor your cancer-fighting white blood cells by wearing white, snap a selfie, and share why you support cancer immunotherapy research with the hashtag #Immune2Cancer on Twitter, Instagram, or Facebook.
Join the Cancer Research Institute for a live discussion with CRI immunotherapy experts followed by audience Q&A on how science from the frontlines of immuno-oncology is helping inform strategies to treat and prevent COVID-19.
In this webinar for patients and caregivers, Corrie Painter, Ph.D., (The Broad Institute) and Eliezer Van Allen, M.D., (Harvard Medical School) discuss the current state of genetic testing for cancer patients in the clinic as well as highlights efforts to tap into the full potential of genome-based medicine.
The Focused Ultrasound Foundation (FUSF) hosts a special conversation with Jill O’Donnell-Tormey, Ph.D., CEO of the Cancer Research Institute (CRI), and Jessica Foley, Ph.D., chief scientific officer of FUSF. Learn more about the lifesaving potential of cancer immunotherapy and the ways that CRI and FUSF are working together to advance exciting research, through a lens of the new COVID-19 environment.
Timothy Fessenden, Ph.D., a CRI Postdoctoral Fellow at the Massachusetts Institute of Technology, will take over the Cancer Research Institute Twitter account (@CancerResearch) and share a day in the life of a scientist. Dr. Fessenden, who regularly tweets from @timisstuck, is using novel imaging approaches to define how the actomyosin cell “skeleton” enables dendritic cells to carry out their highly specialized functions during the sensing and elimination of tumors.
Learn about headline-grabbing research, practice-changing medicine, and new innovations in cancer immunotherapy from the second half of the American Association of Cancer Research meeting (June 22-24).